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OBJECTIVE: The failure to wean from mechanical ventilation is related to worse outcomes after cardiac surgery.
The aim of this study was to evaluate whether the serum level of B-type natriuretic peptide is a predictor of
weaning failure from mechanical ventilation after cardiac surgery.
METHODS: We conducted a prospective, observational cohort study of 101 patients who underwent on-pump
coronary artery bypass grafting. B-type natriuretic peptide was measured postoperatively after intensive care
unit admission and at the end of a 60-min spontaneous breathing test. The demographic data, hemodynamic
and respiratory parameters, fluid balance, need for vasopressor or inotropic support, and length of the
intensive care unit and hospital stays were recorded. Weaning failure was considered as either the inability to
sustain spontaneous breathing after 60 min or the need for reintubation within 48 h.
RESULTS: Of the 101 patients studied, 12 patients failed the weaning trial. There were no differences between
the groups in the baseline or intraoperative characteristics, including left ventricular function, EuroSCORE and
lengths of the cardiac procedure and cardiopulmonary bypass. The B-type natriuretic peptide levels were
significantly higher at intensive care unit admission and at the end of the breathing test in the patients with
weaning failure compared with the patients who were successfully weaned. In a multivariate model, a high B-
type natriuretic peptide level at the end of a spontaneous breathing trial was the only independent predictor
of weaning failure from mechanical ventilation.
CONCLUSIONS: A high B-type natriuretic peptide level is a predictive factor for the failure to wean from
mechanical ventilation after cardiac surgery. These findings suggest that optimizing ventricular function should
be a goal during the perioperative period.
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& INTRODUCTION
The failure to wean from mechanical ventilation after
cardiac surgery is associated with worse outcomes, includ-
ing increased length of hospital stays and higher costs (1-3).
In a prospective study of 885 patients who underwent
coronary artery bypass grafting (CABG), Wong et al. (4)
identified increased age, female gender, the postoperative
use of an intra-aortic balloon pump (IABP), the use of
inotropes, bleeding, and atrial arrhythmia as risk factors for
weaning failure and prolonged mechanical ventilation.
Perioperative ventricular dysfunction and cardiac failure
are frequent causes of weaning failure from mechanical
ventilation (4). Prolonged cardiopulmonary bypass (CPB),
inadequate myocardial protection during surgery, perio-
perative myocardial ischemia and previous left ventricular
dysfunction are associated with a higher incidence of
perioperative heart failure (5,6). A diagnosis of low output
syndrome after surgery is suggested by decreased central
venous oxygen saturation (ScvO2), low urine output, low
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cardiac index, high cardiac filling pressure and elevated
levels of B-type natriuretic peptide (BNP) (7-10).
BNP is produced by cardiac ventricular myocytes in
response to volume or pressure overload. Active BNP and
its inactive form, NT-proBNP, are derived from the cleavage
of their precursor molecule, proBNP. BNP decreases
systemic vascular resistance, improves myocardial relaxa-
tion, increases natriuresis and suppresses endothelin and
the renin-angiotensin system (10). The BNP levels are
increased in patients who have left ventricular dysfunction,
right ventricular dysfunction or valvular dysfunction.
Therefore, BNP is considered to be a quantitative biomarker
of heart failure (10). BNP levels are also related to left
ventricular dysfunction in the postoperative period, includ-
ing after cardiac surgery (11-20). In a prospective study,
Zapata et al. evaluated the value of the BNP level as a
marker of failure to wean from mechanical ventilation in a
mixed population of 100 medical and surgical patients
(excluding cardiac surgery patients) who were treated with
mechanical ventilation for over 48 h (21). BNP levels
predicted failure to wean cases that were caused by
ventricular dysfunction, and a DBNP of 48 ng/L identified
heart failure as the cause of failed SBT, with 91.7%
sensitivity and 88.5% specificity (21).
We hypothesized that BNP levels could help in the early
identification of patients who cannot be weaned from
mechanical ventilation due to postoperative ventricular
dysfunction after cardiac surgery.
& MATERIAL AND METHODS
The study was approved by the Ethics Committee, and
written informed consent was obtained from all patients.
We prospectively included all of the patients older than 18
years who underwent elective CABG surgery with CPB
during a 1-year period from January 2009 and January 2010
at Heart Institute, University of Sao Paulo. The exclusion
criteria were a history of pulmonary disease or chronic renal
failure, the need for IABP and consent refusal.
The patients were anesthetized according to our standard
institutional protocol for CABG surgery. Preoperative
medication consisted of midazolam (0.1 to 0.2 mg/kg given
orally 30 minutes before surgery). Anesthesia was induced
with fentanyl (3-5 mg/kg), midazolam (0.05 mg/kg), etomi-
date (0.2- 0.3 mg/kg), and pancuronium bromide (0.1 mg/
kg). Anesthesia was maintained with isoflurane in oxygen
and fentanyl as needed. During CPB, additional doses of
midazolam and pancuronium were administered as
required to reach a bispectral index of approximately 40-
60. After the tracheal intubation, all of the patients received
invasive mechanical ventilation with intermittent positive
pressure with a tidal volume of 8 mL/kg, positive end-
expiratory pressure of 5 to 8 cm H2O, and fraction of
inspired oxygen (FiO2) of 0.6 to 1 to maintain the arterial
oxygen saturation above 95%. During surgery, the patients
were monitored with a central venous line and indwelling
radial artery catheter. Forty-four patients also had a
pulmonary artery catheter inserted if the surgical and
anesthesiology teams believed that it was warranted. In
these patients, the cardiac index was obtained from a
continuous cardiac output monitor, Vigilance II (Edwards
Lifesciences, Irvine, CA 92614 USA).
Preoperative information, including demographic data,
preoperative left ventricular ejection fraction (LVEF), and
the European system for cardiac operative risk evaluation
score (EuroSCORE) (22), were obtained for all patients. The
intraoperative data, including the cardiac procedure and
CPB durations and the use of inotropes or vasopressors,
were also recorded. After ICU admission, the following
hemodynamic parameters were obtained and recorded:
heart rate, mean arterial pressure (MAP), central venous
pressure (CVP), pulmonary arterial pressures, pulmonary
capillary wedge pressure, cardiac output, cardiac index and
systemic vascular resistance (SVR). We also recorded the
mechanical ventilation parameters, including the ventilation
mode, plateau pressure and positive end-expiratory pres-
sure (PEEP), respiratory rate in controlled and spontaneous
mode, fraction of inspired oxygen (FiO2), oxygen saturation
by pulse oximetry (SpO2), tidal volume and minute volume,
rapid shallow breathing index or respiratory rate/tidal
volume ratio and static respiratory system compliance
(23,24).
A blood gas analysis and measurement of hemoglobin
levels were performed and recorded after ICU admission
every 6 h during the first 24 h after cardiac surgery. The
TriageH BNP Test (Biosite, San Diego, CA, USA) was used to
determine the BNP levels in the plasma specimens through
immunofluorescence, with EDTA as the anticoagulant. The
BNP levels were measured immediately after ICU admis-
sion and at the end of the spontaneous breathing test (SBT).
The fluid balance, need for vasopressor or inotropic
support, and length of the ICU and hospital stays were
also recorded.
Weaning protocol
After ICU admission, all of the patients were initially
ventilated using the following parameters: synchronized
intermittent mandatory ventilation (SIMV) using pressure-
controlled ventilation with an I/E ratio of 1:2 and enough
support pressure to give a tidal volume of approximately
8 mL/kg, 5 cm H2O PEEP, respiratory rate of 12 breaths/
min, and FiO2 of 60% or greater if the SpO2 was less than
90%. The degree of support was reduced, if possible, by 2 to
4 cm H2O at least hourly. The first spontaneous breathing
test was given if the patients were awake and hemodyna-
mically stable, as defined by the absence of bleeding (chest
tube drainage #100 ml per hour or #300 mL in one hour),
ScvO2.65%, CI.2.2 L/min/m
2 and MAP.65 mmHg with
low-dose norepinephrine #0.2 mg/Kg/min) or no vasopres-
sor agents. Additionally, SBT was started after correcting
acid-base and electrolyte disorders. The SBT test lasted
60 min and was considered failed if the patient presented
with one or more of the following signs at the end of the first
SBT: respiratory rate ,35 breaths/min; heart rate ,140
beats/min; SpO2,90% or PaO2,60 mmHg; respiratory
acidosis (pH,7.3 or PaCO2.50 mmHg); signs of respira-
tory distress, such as thoracoabdominal dyssynchrony,
anxiety and diaphoresis, or reintubation within 48 h in
patients who were successful in the first SBT.
Statistical analysis
We compared the baseline characteristics, follow-up
measures, and clinical outcomes between the groups.
Continuous variables were tested for normal distribution
using the Kolmogorov-Smirnov test and compared using
Student’s t test or the Mann-Whitney U-test. The sample
size was calculated based on a power of 80% and a 5% type-
I error. Estimating an event incidence of 10%, 158 patients
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were needed to complete the study. An interim analysis was
scheduled after 101 patients had been enrolled in the study.
The results are expressed as means with 95% confidence
intervals (CIs) or medians with interquartile ranges (IQRs).
A multiple logistic regression analysis was performed to
assess the predictive factors for weaning failure from
mechanical ventilation, and the significance level was set
at p,0.10 in the univariate model (i.e., the patient age, body
mass index [calculated as weight in kilograms divided by
height in meters squared], comorbidity, left ventricular
ejection fraction, EuroSCORE, surgery type, CPB duration,
initial and final hemoglobin concentrations, lactate concen-
tration, and ScvO2 and BNP levels). We built a multivariate
Cox proportional hazard model in the overall population
with weaning failure as the dependent factor using the
variables above.
To determine the best cut-off for BNP, we calculated the
area under the receiver operating characteristic curve (AUC)
and compared the BNP levels in the failed weaning group
with those in the successful weaning group.
A two-sided p-value,0.05 was considered statistically
significant. The statistical analyses were performed using
SPSS version 18.0 (SPSS Inc., Chicago, IL).
& RESULTS
An interim analysis was performed when 101 patients
had been included, and because a significant p-value was
found, we interrupted the data collection. Of the 101
patients studied, 12 failed the weaning trial. Of those 12
patients, five required reintubation, and seven were weaned
from mechanical ventilation after they failed to wean in the
first SBT. There were no differences between the groups in
their baseline or intraoperative characteristics, including the
left ventricular function, EuroSCORE, and the durations of
the cardiac procedure and CPB bypass (Table 1). The
patients who failed weaning had longer ICU (9 (4-14) vs. 3
(2-5), p= 0.024) and hospital (15 (13-20) vs. 8 (7-13), p= 0.047)
lengths of stay compared with successfully weaned patients.
The patients who failed to wean from mechanical
ventilation had higher CVP values at the end of the SBT
than the patients who weaned successfully (11 (9-15) vs. 9 (5-
10) mmHg, p= 0.023); they also had lower ScvO2 values (62
[58-65] vs. 69% [68-71], p= 0.002) at this time point and
required higher doses of dobutamine (15 (11-18) vs. 12 (9-16)
mg/Kg/min, p= 0.044) (Table 2). There were no differences
between the groups in the other hemodynamic variables or
in the cumulative fluid balance.
The BNP levels were significantly higher in the patients
who failed to wean compared with those who weaned
successfully, both at ICU admission (214 ng/mL [65-487] vs.
73 [28-127], p= 0.02) and after the SBT (416 ng/mL [311-561]
vs. 140 [80-226], p,0.001) (Table 2). In the multivariate
model, only BNP at the end of the SBT (BNP-2) was
predictive of weaning failure from mechanical ventilation
(odds ratio [OR], 1.006 per ng/mL [95% CI, 1.003-1.009];
p,0.001). A BNP concentration of 299 ng/L at the end of the
SBT identified weaning failure with 92% sensitivity and 88%
specificity, with an AUC of 0.91 (CI 95% [0.86 - 0.97],
p,0.001) (Figure 1). Figure 2 shows the BNP concentrations
for the individual patients.
Clinical outcomes
A total of 716 patients were assessed for eligibility during
the study period. In total, 101 patients were enrolled, and
the mortality rate was 5%. The patients who failed to wean
from mechanical ventilation after the first SBT had higher
ICU mortality rates than the patients who did not fail (3
[25%] vs. 2 [2.2%], p,0.0011). Five patients in the failure
group were reintubated within 48 h after the SBT because of
congestive heart failure. Two of the reintubated patients
died from cardiogenic shock. Seven patients had failure to
wean in the first SBT but were not reintubated in the first
48 h. One of these patients died from pneumonia, septic
shock and multiple organ failure.
& DISCUSSION
Our study shows that a high level of BNP is an
independent risk factor for the failure to wean from
mechanical ventilation after cardiac surgery. In clinical
practice, BNP levels are widely used to diagnose and
stratify risk in heart failure patients and as a predictor of
outcomes, including re-hospitalization and death (10,25).
An elevated BNP level is considered to be a biomarker of
ventricular dysfunction and can identify early decompen-
sated heart failure after cardiac surgery (11-14,16-20,25,26).
Elevated postoperative BNP levels have also been asso-
ciated with prolonged hospital stays and mortality in
patients undergoing cardiac surgery (11,17,18).
Underlying left ventricular dysfunction is an important
cause of weaning failure in critically ill patients, particularly
during the postoperative period after cardiac surgery, and
Table 1 - Baseline, intraoperative characteristics and clinical outcomes of patients.
Variable Total (101) Successful weaning (n= 89) Failure to wean (n =12) p-value
Sex*
Male 76 (75.2%) 69 (77.5%) 7 (58.3%) 0.165
Female 25 (24.8%) 20 (22.5%) 5 (41.7%)
Age (years)** 63 (61-65) 63 (61-65) 63 (55-72) 0.289
LVEF (%)*** 54 (40-64) 54 (40-64) 56 (40-68) 0.560
EuroSCORE*** 5 (3-7) 4 (3-7) 6 (4-8) 0.246
Duration of procedure (min)*** 270 (240-330) 270 (240-330) 283 (240-383) 0.281
Duration of CBP (min)*** 95 (80-110) 94 (80-108) 111 (91-120) 0.433
Duration of mechanical ventilation (min) *** 420 (360-613) 420 (360-625) 488 (390-559) 0.868
ICU length of stay (days) *** 3 (2-5) 3 (2-5) 9 (4-14) 0.024
Hospital length of stay (days) *** 9 (7-14) 8 (7-13) 15 (13-20) 0.047
Hospital Mortality 5 (5%) 2 (2,2%) 3 (25%) 0.011
*Chi-square test, **mean (95% confidence Interval), t-test, ***median (interquartile range), Mann-Whitney test. EuroSCORE: European System for
Cardiac Operative Risk Evaluation; LVEF: left ventricular ejection fraction; CPB: cardiopulmonary bypass.
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can be the result of perioperative myocardial ischemia,
prolonged CPB, or inadequate myocardial protection (27-
30). This condition may be difficult to recognize within the
first 24 h after cardiac surgery. Previous studies have
reported that early indirect parameters of cardiac function,
such as capnometric recirculation gas tonometry and gastric
Table 2 - Hemodynamic, respiratory and gas exchange variables.
Variable Successful weaning (n =89) Failure to wean (n=12) p-value
Hemodynamic
HR-1 (beats/min)* 96 (92-100) 93 (80-105) 0.435
HR-2 (beats/min)* 103 (101-106) 96 (89-103) 0.087
MAP-1 (mmHg)* 92 (89-96) 93 (83-102) 0.983
MAP-2 (mmHg)* 89 (87-92) 85 (78-93) 0.239
PAOP-1 (mmHg)*$ 14 (13-15) 14 (10-17) 0.855
PAOP-2 (mmHg)*$ 10 (9-12) 12 (9-15) 0.440
CVP-1 (mmHg)* 10 (9-11) 10 (8-12) 0.883
CVP-2 (mmHg)** 9 (5-10) 11 (9-15) 0.023
PCP-1 (%)*$ 14 (13-15) 14 (10-17) 0.855
PCP-2 (%)*$ 10 (9-12) 12 (9-15) 0.440
ScvO2-1 (%)** 77 (70-81) 77 (69-77) 0.781
ScvO2-2 (%)* 69 (68-71) 62 (58-65) 0.002
CI-1 (L/min/m2)$* 3.17 (2.83-3.50) 2.75 (2.31-3.20) 0.361
CI-2 (L/min/m2)$* 3.33 (3.08-3.58) 2.76 (2.21-3.30) 0.068
Lactate-1 (mmol/L)** 4.0 (2.9-6.1) 2.3 (1.3-5.0) 0.313
Lactate-2 (mmol/L)** 2.9 (1.8-4.6) 1.9 (1.4-3.6) 0.296
Hb-1 (g/dL)** 10.8 (9.8-11.8) 9.8 (9.2-11.7) 0.154
Hb-2 (g/dL)** 10.6 (9.6-11.8) 10 (8.9-10.2) 0.084
Dobutamine-1** 10 (8-17) 14 (9-18) 0.519
Dobutamine-2** 12 (9-16) 15 (11-18) 0.044
Respiratory
PaO2-1 (mmHg)* 145 (136-154) 142 (113-171) 0.754
PaO2-2 (mmHg)** 107 (90-143) 117 (88-152) 0.550
PaCO2-1 (mmHg)** 40 (36-44) 39 (36-45) 0.806
PaCO2-2 (mmHg)** 37 (33-40) 37 (34-41) 0.303
pH-1** 7.3 (7.3-7.4) 7.4 (7.3-7.4) 0.313
pH-2** 7.4 (7.3-7.4) 7.4 (7.3-7.4) 0.232
Tobin-2** 36 (26-45) 45 (29-83) 0.098
SC-1 (mL/cmH2O)** 38 (32-49) 39 (33-51) 0.889
Natriopeptides (ng/L)
BNP-1** 73 (28-127) 214 (65-487) 0.020
BNP-2** 140 (80-226) 416 (311-561) ,0.001
*mean (95% Confidence Interval), t-test, **median (Interquartile Range), Mann-Whitney test. $evaluated in the 44 patients who had a pulmonary artery
catheter inserted – 36 in the successful weaning group and 8 in the failure to wean group. 1- at intensive care unit admission; 2- at the end of the
spontaneous breathing test; HR: heart rate; MAP: mean arterial pressure; PAOP: pulmonary artery occlusion pressure; CVP: central venous pressure; ScvO2:
central venous oxygen saturation; Hb: hemoglobin concentration; SC= Static compliance; CI: cardiac index.
Figure 1 - Area under receiving operating characteristic curve for
BNP-2 (at the end of spontaneous breathing test) to predict
weaning failure.
Figure 2 - Individual values of BNP concentration. A cut-off of
299 ng/L at the end of the SBT predicted failure to wean from
mechanical ventilation after cardiac surgery with 92% sensitivity
and 87% specificity. Red dots represent patients with weaning
failure.
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intramucosal pH, were altered in patients who presented
with failure to wean from mechanical ventilation. These
findings can be explained by the likelihood that the
increased respiratory workload during spontaneous test
breathing can induce an intestinal mucosa hypoperfusion
because of the adrenergic response and effort required to
increase the blood flow to the respiratory muscles (31-33).
Similarly, the BNP levels during the spontaneous breathing
test might help physicians identify earlier those patients
with postoperative heart failure and support decisions to
discontinue mechanical ventilation after cardiac surgery,
potentially decreasing the risk of weaning failure (6,18,21).
All of the patients with weaning failure in the current
study had higher BNP levels both at their ICU admissions
and at the end of the SBT compared with the patients who
had successful weaning. The highest BNP levels were found
at the end of the SBT, suggesting that postoperative left
ventricular dysfunction was involved in the weaning
failure. In addition, these patients had higher CVP and
lower ScvO2 levels and needed higher doses of dobutamine
compared with the patients who were successfully weaned.
Paulus et al. (34) reported that in patients with left
ventricular dysfunction who had presented a failure in the
first or additional spontaneous breathing tests after cardiac
surgery, the use of enoximone, a phosphodiesterase III
inhibitor, was associated with an improvement in hemody-
namic parameters and successful withdrawal of mechanical
ventilation. Although these hemodynamic parameters were
not predictors of weaning failure in our study, they
reinforce our hypothesis that underlying heart failure
caused weaning failure in this subgroup of patients.
A previous study showed that increased age, female
gender, the postoperative use of an intra-aortic balloon
pump (IABP), inotropes, bleeding, and atrial arrhythmia
were risk factors of delayed extubation after cardiac surgery
(4). Our data did not show any differences in gender.
However, our findings suggested that poor ventricular
function, expressed through high levels of BNP, is a
predictor of weaning failure after cardiac surgery.
In our study, the prevalence of weaning failure was 12%.
This failure rate is higher than that reported in other studies
(1), most likely because our study was performed in a
cardiac surgery referral center and included severely ill
patients, as shown by the high EuroSCOREs (22). The
patients who had weaning failure in our study may have
developed myocardial dysfunction secondary to CPB. A
CPB duration of more than 120 minutes has been considered
a predictive factor for weaning failure in patients after
cardiac surgery in previous studies (35), but there was no
significant difference in the duration of CPB between our
groups. Moreover, none of the patients with weaning failure
met the perioperative myocardial infarction criteria.
Nevertheless, the etiology of myocardial dysfunction after
CPB is multifactorial and can occur even without prolonged
CPB or perioperative infarction (6). Using transesophageal
echocardiography, Bernard et al. described a 30% rate of
diastolic dysfunction after cardiac surgery with CPB (27).
If BNP levels are predictors of weaning failure from
mechanical ventilation in patients after cardiac surgery, as
suggested by our results, and ventricular dysfunction is one
cause of weaning failure, then optimizing ventricular
function may result in better outcomes after cardiac surgery.
A bundle of interventions could be used to optimize
ventricular function during the perioperative period in such
patients, including effective myocardial protection during
CPB and the judicious administration of inotropic agents
and vasodilators to obtain adequate cardiac indices and
ScvO2 levels (6). The careful evaluation of fluid status is also
needed to prevent elevated filling pressures and pulmonary
congestion.
Our study has several limitations. First, it was an
observational and single-center study with a small number
of patients and relatively few failure events. Second, BNP
levels can be altered in various conditions in patients
undergoing cardiac surgery, and we are unable to identify
the exact cause of the myocardial dysfunction that caused
the weaning failure in our patients. Third, there are many
other conditions in critically ill patients that may be
associated with increased BNP levels. Therefore, these
investigations should be extended to a larger patient
population in a multicenter setting.
In conclusion, our study demonstrated that a high BNP
level is a predictor of weaning failure from mechanical
ventilation in patients after cardiac surgery. Therefore,
measuring BNP levels may help to guide and evaluate the
effects of therapeutic strategies, such as optimizing ven-
tricular function during cardiac surgery, prior to weaning
from mechanical ventilation.
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